Enochian Biosciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENOB and other ETFs, options, and stocks.

About ENOB

Enochian Biosciences, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. 

CEO
Mark Richard Dybul
CEOMark Richard Dybul
Employees
11
Employees11
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2011
Founded2011
Employees
11
Employees11

ENOB Key Statistics

Market cap
64.07M
Market cap64.07M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
72.58K
Average volume72.58K
High today
$1.25
High today$1.25
Low today
$1.05
Low today$1.05
Open price
$1.07
Open price$1.07
Volume
74.27K
Volume74.27K
52 Week high
$11.99
52 Week high$11.99
52 Week low
$0.99
52 Week low$0.99

ENOB Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Dec 16, After Hours
ActualExpected Dec 16, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.